Clinical trial
Modafinil in Treating Fatigue in Patients Receiving Chemotherapy for Cancer
NCT00042848 · Gary Morrow, Other · Completed
Key facts
| NCT number | NCT00042848 |
|---|---|
| Title | Modafinil in Treating Fatigue in Patients Receiving Chemotherapy for Cancer |
| Official title | Phase III Randomized, Placebo-Controlled, Double-Blind Trial Of The Effect Of Modafinil On Fatigue In Cancer Patients Receiving Chemotherapy |
| Lead sponsor | Gary Morrow, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Fatigue, Unspecified Adult Solid Tumor, Protocol Specific |
| Intervention type | Drug |
| Interventions | modafinil |
| Enrollment | 837 |
| Start date | Aug 1, 2002 |
| Primary completion | Apr 1, 2007 |
| Completion | Oct 1, 2007 |
| First posted | Jan 27, 2003 |
| Last update posted | Oct 15, 2015 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: